OS Therapies Incorporated
OSTX
$1.86
$0.031.64%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -175.70% | -212.13% | -223.70% | -148.55% | -121.18% |
| Total Depreciation and Amortization | 335.95% | 17,300.00% | 12,864.29% | 17,007.14% | 2,338.30% |
| Total Amortization of Deferred Charges | 228.61% | -22.38% | -27.22% | -100.00% | -85.17% |
| Total Other Non-Cash Items | 249.22% | 994.28% | 1,227.17% | -- | -- |
| Change in Net Operating Assets | 2,083.32% | 2,097.78% | 7,117.80% | 4,003.17% | -31.37% |
| Cash from Operations | -60.30% | -52.35% | -95.52% | -122.93% | -253.49% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -68.66% | -- | -- | -- |
| Cash from Investing | 100.00% | -68.66% | -- | -- | -- |
| Total Debt Issued | -- | 103.89% | -- | -100.00% | -100.00% |
| Total Debt Repaid | -- | -- | -- | 100.00% | -- |
| Issuance of Common Stock | 108.25% | 162.51% | 97.90% | 67.40% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -99.99% | -82.59% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,234.98% | -1,419.80% | -- | -1,311.88% | 152.21% |
| Cash from Financing | 8.15% | 3.60% | -26.11% | 75.41% | 344.31% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -195.93% | -171.53% | -195.80% | -99.00% | 5,836.62% |